IQVIA AI Assistant wins 2024 PM360 Innovation Award for Artificial Intelligence
IQVIA AI Assistant has been awarded the 2024 PM360 Innovation Award in the Artificial Intelligence category. Launched in September 2024, this revolutionary tool provides quick, precise answers to complex business questions through a conversational interface with advanced data science capabilities.
The AI Assistant builds on IQVIA's decade-long experience in artificial intelligence and Healthcare-grade AI™, which prioritizes data privacy, security, and regulatory compliance. Currently available solutions include IQVIA Orchestrated Analytics with AI Assistant and IQVIA ChannelDynamics® Verbatim with AI Assistant, with additional offerings planned for launch this year.
These solutions help life sciences companies integrate AI-driven insights into strategic decision-making, enhancing precision and efficiency in commercial analytics and market research. The recognition from PM360, a leading pharmaceutical industry journal, validates IQVIA's commitment to delivering AI solutions that maintain high standards of trust, scalability, and precision.
IQVIA AI Assistant ha ricevuto il 2024 PM360 Innovation Award nella categoria Intelligenza Artificiale. Lanciato a settembre 2024, questo strumento rivoluzionario fornisce risposte rapide e precise a domande aziendali complesse attraverso un'interfaccia conversazionale con capacità avanzate di data science.
L'AI Assistant si basa sull'esperienza decennale di IQVIA nell'intelligenza artificiale e su Healthcare-grade AI™, che dà priorità alla privacy dei dati, alla sicurezza e alla conformità normativa. Le soluzioni attualmente disponibili includono IQVIA Orchestrated Analytics with AI Assistant e IQVIA ChannelDynamics® Verbatim with AI Assistant, con ulteriori offerte in programma per il lancio quest'anno.
Queste soluzioni aiutano le aziende delle scienze della vita a integrare approfondimenti guidati dall'IA nel processo decisionale strategico, migliorando la precisione e l'efficienza nell'analisi commerciale e nella ricerca di mercato. Il riconoscimento da parte di PM360, una rivista leader nel settore farmaceutico, convalida l'impegno di IQVIA nel fornire soluzioni IA che mantengono elevati standard di fiducia, scalabilità e precisione.
IQVIA AI Assistant ha sido galardonado con el 2024 PM360 Innovation Award en la categoría de Inteligencia Artificial. Lanzado en septiembre de 2024, esta herramienta revolucionaria proporciona respuestas rápidas y precisas a preguntas comerciales complejas a través de una interfaz conversacional con capacidades avanzadas de ciencia de datos.
El AI Assistant se basa en la experiencia de IQVIA de más de diez años en inteligencia artificial y Healthcare-grade AI™, que prioriza la privacidad de los datos, la seguridad y el cumplimiento normativo. Las soluciones actualmente disponibles incluyen IQVIA Orchestrated Analytics with AI Assistant y IQVIA ChannelDynamics® Verbatim with AI Assistant, con ofertas adicionales previstas para su lanzamiento este año.
Estas soluciones ayudan a las empresas de ciencias de la vida a integrar conocimientos impulsados por IA en la toma de decisiones estratégicas, mejorando la precisión y la eficiencia en el análisis comercial y la investigación de mercado. El reconocimiento de PM360, una revista líder en la industria farmacéutica, valida el compromiso de IQVIA de ofrecer soluciones de IA que mantienen altos estándares de confianza, escalabilidad y precisión.
IQVIA AI Assistant는 인공지능 부문에서 2024 PM360 Innovation Award를 수상했습니다. 2024년 9월에 출시된 이 혁신적인 도구는 고급 데이터 과학 기능을 갖춘 대화형 인터페이스를 통해 복잡한 비즈니스 질문에 빠르고 정확한 답변을 제공합니다.
AI Assistant는 데이터 프라이버시, 보안 및 규제 준수를 우선시하는 Healthcare-grade AI™와 함께 IQVIA의 10년 이상의 인공지능 경험을 기반으로 합니다. 현재 제공되는 솔루션에는 IQVIA Orchestrated Analytics with AI Assistant와 IQVIA ChannelDynamics® Verbatim with AI Assistant가 포함되며, 올해 추가 솔루션이 출시될 예정입니다.
이 솔루션들은 생명 과학 회사들이 AI 기반 인사이트를 전략적 의사 결정에 통합하도록 도와주며, 상업 분석 및 시장 조사에서의 정확성과 효율성을 향상시킵니다. 제약 산업의 주요 저널인 PM360의 인정은 IQVIA가 신뢰성, 확장성 및 정확성을 유지하는 AI 솔루션을 제공하기 위한 헌신을 확인해줍니다.
IQVIA AI Assistant a reçu le 2024 PM360 Innovation Award dans la catégorie Intelligence Artificielle. Lancé en septembre 2024, cet outil révolutionnaire fournit des réponses rapides et précises à des questions commerciales complexes via une interface conversationnelle dotée de capacités avancées en science des données.
L'AI Assistant s'appuie sur l'expérience de plus de dix ans d'IQVIA en intelligence artificielle et sur Healthcare-grade AI™, qui priorise la confidentialité des données, la sécurité et la conformité réglementaire. Les solutions actuellement disponibles incluent IQVIA Orchestrated Analytics with AI Assistant et IQVIA ChannelDynamics® Verbatim with AI Assistant, avec d'autres offres prévues pour lancement cette année.
Ces solutions aident les entreprises des sciences de la vie à intégrer des insights guidés par l'IA dans la prise de décision stratégique, améliorant ainsi la précision et l'efficacité dans l'analyse commerciale et la recherche de marché. La reconnaissance de PM360, un journal de premier plan dans l'industrie pharmaceutique, valide l'engagement d'IQVIA à fournir des solutions d'IA qui maintiennent des normes élevées de confiance, d'évolutivité et de précision.
IQVIA AI Assistant wurde mit dem 2024 PM360 Innovation Award in der Kategorie Künstliche Intelligenz ausgezeichnet. Das im September 2024 eingeführte revolutionäre Tool bietet schnelle, präzise Antworten auf komplexe Geschäftsfragen über eine konversationelle Schnittstelle mit fortschrittlichen Datenwissenschaftsfähigkeiten.
Der AI Assistant baut auf IQVIAs jahrzehntelanger Erfahrung in der künstlichen Intelligenz und Healthcare-grade AI™ auf, die Datenschutz, Sicherheit und regulatorische Compliance priorisiert. Zu den derzeit verfügbaren Lösungen gehören IQVIA Orchestrated Analytics with AI Assistant und IQVIA ChannelDynamics® Verbatim with AI Assistant, mit weiteren Angeboten, die in diesem Jahr auf den Markt kommen sollen.
Diese Lösungen helfen Unternehmen der Lebenswissenschaften, KI-gesteuerte Erkenntnisse in die strategische Entscheidungsfindung zu integrieren und die Präzision und Effizienz in der kommerziellen Analyse und Marktforschung zu verbessern. Die Anerkennung von PM360, einer führenden Fachzeitschrift der Pharmaindustrie, bestätigt IQVIAs Engagement, KI-Lösungen anzubieten, die hohe Standards in Bezug auf Vertrauen, Skalierbarkeit und Präzision aufrechterhalten.
- None.
- None.
Launched in September 2024, IQVIA AI Assistant revolutionizes insight generation by providing rapid, relevant and precise answers to complex business questions. Using a conversational interface with advanced data science, it makes complex analytics accessible to a wide variety of users and provides near real-time insights.
IQVIA AI Assistant builds upon IQVIA’s decade of experience in artificial intelligence and developing Healthcare-grade AI™, a proven and trusted foundation with data privacy, security and regulatory compliance at its core. Healthcare-grade AI™ represents IQVIA’s commitment to using AI responsibly, with AI-powered capabilities built on best-in-class approaches to privacy, regulatory compliance and patient safety, and delivering AI to the high standards of trust, scalability and precision demanded by the industry.
“We are thrilled to have won an Innovation Award from PM360 for IQVIA AI Assistant. This is recognition of how IQVIA AI Assistant is transforming the way healthcare and life sciences customers obtain critical insights,” said Bhavik Patel, president of Commercial Solutions, IQVIA. “This is what IQVIA Healthcare-grade AI is all about — delivering the promise of AI without losing sight of the quality, precision and trust we all expect.”
IQVIA Orchestrated Analytics with AI Assistant and IQVIA ChannelDynamics® Verbatim with AI Assistant are now available and additional offerings are set to launch this year. These solutions empower life sciences companies to seamlessly integrate AI-driven insights into their strategic decision-making processes to enhance the precision and efficiency of key life sciences programs, such as commercial analytics and market research.
PM360 is a journal that focuses on delivering the full spectrum of practical information necessary for pharmaceutical brand managers and marketing professionals to succeed in their roles. The PM360 Innovation Awards recognize the most innovative companies, products, services and strategies in the life sciences industry. The scope of the AI category is defined as AI/ML companies or products that are helping to improve processes within healthcare and the life sciences or marketing.
For more information about IQVIA AI Assistant and other IQVIA solutions, please visit www.iqvia.com.
About IQVIA
IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI™, advanced analytics, the latest technologies and extensive domain expertise. IQVIA is committed to using AI responsibly, with AI-powered capabilities built on best-in-class approaches to privacy, regulatory compliance and patient safety, and delivering AI to the high standards of trust, scalability and precision demanded by the industry. With approximately 88,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.
IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250224677443/en/
Kerri Joseph, IQVIA Investor Relations (kerri.joseph@iqvia.com)
+1.973.541.3558
Alissa Maupin, IQVIA Media Relations (alissa.maupin1@iqvia.com)
+1.919.923.6785
Source: IQVIA
FAQ
What award did IQVIA (IQV) win for its AI Assistant in 2024?
When was the IQVIA AI Assistant launched?
What are the current available AI Assistant solutions from IQVIA (IQV)?
How does IQVIA's Healthcare-grade AI ensure data security?
What business functions does IQVIA's AI Assistant enhance?
